Onderneming Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CBI
IL0011042806
Holdingvennootschappen
Vakgebied
Verkoop per activiteit
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Verkoop per regio
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | 70 | 15-05-07 | |
Iris Sadeh
AUD | Comptroller/Controller/Auditor | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Gabriel Barbash
BRD | Director/Board Member | 74 | 25-03-03 |
Director/Board Member | 39 | 05-12-17 | |
Nufar Malovani
BRD | Director/Board Member | 46 | 19-11-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 161 256 549 | 55 870 242 ( 34,65 %) | 4 410 349 ( 2,735 %) | 34,65 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
GAMIDA CELL LTD. 1.95% | 2 581 746 | 1.95% | 92 943 $ |
Bedrijfsgegevens
Clal Biotechnology Industries Ltd.
Triangle Building Azrieli Center 3
67023, Tel Aviv
+
http://www.cbi.co.ilSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,98% | 75,78 mld. | |
+59,45% | 17,7 mld. | |
+2,74% | 15,69 mld. | |
+8,60% | 14,04 mld. | |
-0,04% | 12,37 mld. | |
+8,96% | 11,98 mld. | |
+5,82% | 10,82 mld. | |
+34,35% | 10,08 mld. | |
-1,92% | 9,69 mld. |